Managed Care Is Moving Toward Restricting DTC Advertised Drugs - Cigna VP
Restrictions on direct-to-consumer advertised drugs are being considered by managed care organizations in order to control increasing costs driven by patient demand, Cigna Healthcare VP Peter Penna told an Institute for International Research conference Sept. 15.
You may also be interested in...
ProMedex' Symptom-Free allergy program to counter DTC-stimulated demand for antihistamines plans to enroll 3,000 patients with allergic rhinitis in the first two months.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011